Wilson's disease: An update

Nature Clinical Practice Neurology

Volumn 2, Issue 9, 2006, Pages 482-493

  Das, Shyamal K ^a   Ray, Kunal ^b  

^a BANGUR INSTITUTE OF NEUROLOGY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BACLOFEN; BOTULINUM TOXIN; CHAPERONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; COPPER; LACTULOSE; LEVODOPA; NEUROLEPTIC AGENT; PENICILLAMINE; STEROID; TETRATHIOMOLYBDATE AMMONIUM; TIZANIDINE; TRIENTINE; WILSON DISEASE PROTEIN; ZINC ACETATE; ZINC SULFIDE;

ABDOMINAL DISCOMFORT; ANEMIA; AUTOIMMUNE DISEASE; AUTOSOMAL RECESSIVE INHERITANCE; BIOACCUMULATION; BLOOD ANALYSIS; BONE MARROW SUPPRESSION; BRAIN TISSUE; CHELATION THERAPY; CLINICAL FEATURE; COPPER METABOLISM; DISEASE EXACERBATION; DRUG DESIGN; DRUG HYPERSENSITIVITY; EXON; FAMILY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GOODPASTURE SYNDROME; HETEROZYGOTE DETECTION; HUMAN; INBORN ERROR OF METABOLISM; LIVER; LIVER DISEASE; LIVER TRANSPLANTATION; METABOLIC DISORDER; NEUROLOGIC DISEASE; NEUROMUSCULAR JUNCTION DISORDER; NEUROPATHY; POLYMERASE CHAIN REACTION; POLYMYOSITIS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SCORING SYSTEM; SIDEROBLASTIC ANEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; BRAIN; CATION TRANSPORT PROTEINS; CERULOPLASMIN; CHELATING AGENTS; COPPER; HEPATOLENTICULAR DEGENERATION; HUMANS;

EID: 33747752509     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0291     Document Type: Review

References (63)

1. Wilson SAK (1912) Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver. Brain 34: 295-509
2. Cunning JN (1948) The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration. Brain 71: 410-415
3. Frommer DJ (1974) Defective biliary excretion of copper in Wilson's disease. Gut 15: 125-129
4. Scheinberg DJ and Gitlin D (1952) Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease) Science 116: 484-485
5. Bull PC et al. (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5: 327-337
6. Loudianos G et al. (1999) Molecular characterization of Wilson disease in the Sardinian population - evidence of a founder effect. Hum Mutat 14: 294-303
7. Yamaguchi Y et al. (1993) Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Common 197: 271-277
8. Frydman M et al. (1985) Assignment of the gene for Wilson disease to chromosome 13: Linkage to the esterase D locus. Proc Natl Acad Sc USA 82: 1891-1892
9. Figus A et al. (1995) Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet 57: 1318-1324
10. The Human Gene Mutation Database, Institute of Medical Genetics, Cardiff [http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/120494.html] (accessed June 3 2006)
11. Wilson Disease Mutation Database, Department of Medical Genetics, University of Alberta [http://www.uofa-medical-genetics.org/wilson/ index.php] (accessed June 3 2006)
12. Thomas GR et al. (1995) The Wilson disease gene: Spectrum of mutations and their consequences. Nat Genet 9: 210-217
13. Kim EK et al. (1998) Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease. Hum Mutat 11: 275-278
14. Gupta A et al. (2005) Molecular pathogenesis of Wilson Disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 118: 49-57
15. Petrukhin K et al. (1993) Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 5: 338-343
16. Schiefermeier M et al. (2000) The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain 123: 585-590
17. Vulpe C et al. (1993) Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet 3: 7-13
18. Valentine JS and Gralla B (1997) Delivering copper inside yeast and human cells. Science 278: 817-818
19. Yang XL et al. (1997) Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments. Biochem J 326: 897-902
20. Harris ED (2000) Cellular copper transport and metabolism. Annu Rev Nutr 20: 291-310
21. Schilsky M and Tavill AS (2003) Wilson disease. In Disease of the Liver, edn 9, 1169-1186 (Eds Schiff ER et al.) Philadelphia: Lippincott Williams & Wilkins
22. Sherlock S and Dooley J (Eds; 2002) Wilson disease. In Diseases of the Liver and Biliary System, edn 11, 413-422 Oxford: Blackwell Science
23. Mufti AR et al. (2006) XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell 21: 775-785
24. Scheinberg IH and Sternlieb I (1984) Wilson disease. Philadelphia: WB Saunders
25. Ala A et al. (2005) Wilson disease in septuagenarian siblings: Raising the bar for diagnosis. Hepatology 41: 668-670
26. Le Witt P and Pfeiffe R (2002) Neurologic aspects of Wilson's disease: clinical manifestations and treatment considerations. In Parkinson's Disease and Movement Disorders, edn 4, 240-255 (Eds Jankovic JJ and Tolosa E) Philadelphia: Lippincott Williams & Wilkins
27. Kalra V et al. (2000) Wilson's disease: Early onset and lessons from a pediatric cohort in India. Indian Pediatr 37: 595-601
28. Starosta-Rubinstein S et al. (1987) Clinical assessment of 31 patients with Wilson's disease: Correlations with structural changes on magnetic resonance imaging. Arch Neurol 44: 365-370
29. Jha SK et al. (1998) Wilson's disease: Clinical and radiological features. J Assoc Physicians India. 46: 602-605
30. Brewer GJ (2006) Wilson's disease. In Neurogenetics - scientific and clinical advances, 383-402 (Ed Lynch DR) New York: Taylor & Francis
31. Kwamura N et al. (2004) Serial diffusion weighted MRI in a case of Wilson's disease with acute onset of hemichorea. J Neurol 251: 1413-1414
32. Menkes JH (2003) Wilson disease. In Genetics of movement disorders, 341-352 (Ed Pulsat FM) Amsterdam: Academic Press
33. Meenakshi Sundaram S et al. (2002) Autonomic dysfunction in Wilson's disease - a clinical and electrophysiological study. Clin Auton Res 12: 185-189
34. Prashanth LK et al. (2004) Wilson's disease: Diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry 75: 907-909
35. Ferenci P et al. (2003) Diagnosis and phenotypic classification of Wilson disease: Final report of the proceedings of the working party at the International Meeting on Wilson disease and Menkes disease, Leipzig/ Germany, April 16-18, 2001. Liver Int 23: 139-142
36. Sternlieb I (1990) Perspectives on Wilson's disease. Hepatology 12: 1234-1239
37. Martins da Costa C et al. (1992) Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 15: 609-615
38. Ferenci P et al. (2005) Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol 3: 811-818
39. 65Cu) in the differential diagnosis of Wilson's disease. Clin Sci 88: 727-732
40. Walshe JM (1988) Diagnosis and treatment of presymptomatic Wilson's disease. Lancet 2: 435-437
41. Loudianos G et al. (1994) Improvement of prenatal diagnosis of Wilson disease using microsatellite markers. Prenatal Dian 14: 999-1002
42. Page RA et al. (2004) Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease. Neurology 63: 638-643
43. Kuruvilla A and Joseph S (2000) 'Face of the giant Panda' sign in Wilson's disease: Revisited. Neurol India 48: 395-396
44. Alanen A et al. (1999) Magnetic resonance imaging and proton MR spectroscopy in Wilson's disease. Br J Radiol 72: 749-756
45. Savranlar A et al. (2005) Proton magnetic resonance spectroscopy findings of Wilson's disease: Case report. J Neurol Sci (Turkish) 22: 297-303
46. Van Den Heuvel AG et al. (1997). Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy. Radiology 203: 539-543
47. Lucato LT et al. (2005) Proton MR spectroscopy in Wilson disease: analysis of 36 cases. AJNR Am J Neuroradiol 26: 1066-1071
48. Jeon B et al. (1998) Dopamine transporter imaging with [123I]-beta -CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 65: 60-64
49. Walshe JM (1999) Penicillamine: The treatment of first choice for patients with Wilson's disease. Mov Disord 14: 545-550
50. Walshe JM (1982) Treatment of Wilson's disease with trientine (triethylamine tetramine dihydrochloride). Lancet 1: 643-647
51. Starosta-Rubinstein S (1995) Treatment of Wilson disease. In Treatment of Movement Disorders, 115-151 (Ed Kurlan R) Philadelphia: JB Lippincott Company
52. Brew GJ et al. (2003) Treatment of Wilson disease with ammonium tetrathiomolybdate III: Initial therapy in a total of 55 neurologically affected patients and follow up with zinc therapy. Arch Neurol 60: 378-385
53. Hoogenraad TU et al. (1987) Management of Wilson's disease with zinc sulphate: Experience in a series of 27 patients. J Neurol Sci 77: 137-146
54. Brewer GJ et al. (1983) Oral zinc therapy for Wilson's disease. Ann Intern Med 99: 314-319
55. Brewer GJ et al. (1994) Treatment of Wilson disease with zinc: XIII. Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 123: 849-858
56. Togashi Y et al. (1992) D-penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism. Hepatology 15: 82-87
57. Brewer GJ (1999) Penicillamine should not be used as initial therapy in Wilson's disease. Mov Disord 14: 551-554
58. Brewer GJ et al. (2000) Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. Hepatology 31: 364-370
59. Schilsky ML et al. (1994) Liver transplantation for Wilson's disease: indications and outcome. Hepatology 19: 583-587
60. Bax RT et al. (1998) Cerebral manifestation of Wilson's disease successfully treated with liver transplantation. Neurology 51: 863-865
61. Nazer H et al. (1986) Wilson's disease: Clinical presentation and use of prognostic index. Gut 27: 1377-1381
62. Ha-Hao D et al. (2002) Chances and shortcomings of adenovirus-mediated ATP7B gene transfer in Wilson disease: Proof of principle demonstrated in a pilot study with LEC rats. Z Gastroenterol 40: 209-216
63. Basak SK (Ed; 2006) Diseases of the cornea. In Atlas on Clinical Ophthalmology, 55-94. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd